Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EPS (Weighted Average and Diluted) (2016 - 2025)

MedWellAI (MWAI) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.05 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 16.67% to -$0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.28 through Dec 2025, down 300.0% year-over-year, with the annual reading at -$0.49 for FY2025, 77.52% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.05 at MedWellAI, up from -$0.09 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.11 in Q2 2024, with the low at -$9.75 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.67, with a median of -$0.08 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 222.67% in 2021, then plummeted 31225.59% in 2022.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.0 in 2021, then tumbled by 31225.59% to -$0.7 in 2022, then soared by 81.43% to -$0.13 in 2023, then soared by 53.85% to -$0.06 in 2024, then grew by 16.67% to -$0.05 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.05, -$0.09, and -$0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.